QGEN
Qiagen N.V.
NYSE · Life Sciences Tools & Services
$50.95
-0.28 (-0.55%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.97B | 2.06B | 2.76B | 2.80B | 2.83B |
| Net Income | 83.28M | 78.25M | 136.97M | 113.25M | 136.27M |
| EPS | — | — | — | — | — |
| Profit Margin | 4.2% | 4.0% | 5.0% | 4.1% | 4.8% |
| Rev Growth | -4.2% | -4.2% | +20.2% | +10.7% | +5.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.48B | 1.48B | 2.10B | 2.25B | 2.65B |
| Total Equity | 3.79B | 3.79B | 7.31B | 7.69B | 7.73B |
| D/E Ratio | 0.39 | 0.39 | 0.29 | 0.29 | 0.34 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 106.87M | 106.00M | 256.18M | 241.59M | 268.48M |
| Free Cash Flow | — | — | 170.77M | 174.05M | 184.00M |